We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$246M
AUM Growth
-$27.1M
Cap. Flow
-$37.7M
Cap. Flow %
-15.33%
Top 10 Hldgs %
36.95%
Holding
116
New
41
Increased
15
Reduced
17
Closed
34

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$10.8M
2
ELV icon
Elevance Health
ELV
+$9.58M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$7.09M
4
GILD icon
Gilead Sciences
GILD
+$4.44M
5
ILMN icon
Illumina
ILMN
+$3.65M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$14.5M
2
CI icon
Cigna
CI
+$13.2M
3
MDT icon
Medtronic
MDT
+$7.5M
4
BAX icon
Baxter International
BAX
+$6.8M
5
LLY icon
Eli Lilly
LLY
+$5.65M

Sector Composition

Rank Sector Weight
1 Healthcare 78.04%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
CALL
Cigna
CI
$71.7B
$3.2M 1.3%
+25,000
New +$3.3M
MDRX
27
DELISTED
Veradigm Inc. Common Stock
MDRX
$3.17M 1.29%
250,000
– –
ABBV icon
28
CALL
AbbVie
ABBV
$439B
$3.1M 1.26%
+50,000
New +$3.05M
ONCE
29
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$3.07M 1.25%
+60,000
New +$2.56M
EXEL icon
30
Exelixis
EXEL
$12.9B
$2.73M 1.11%
350,000
+200,000
+133% +$1.15M
AERI
31
DELISTED
Aerie Pharmaceuticals
AERI
$2.64M 1.07%
150,000
+75,000
+100% +$1.21M
TVTY
32
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$2.6M 1.06%
225,000
– –
KITE
33
DELISTED
Kite Pharma, Inc.
KITE
$2.5M 1.02%
50,000
– –
BSX icon
34
Boston Scientific
BSX
$74B
$2.34M 0.95%
100,000
-100,000
-50% -$2.16M
KTWO
35
DELISTED
K2M Group Holdings, Inc
KTWO
$2.17M 0.88%
+140,000
New +$1.97M
AXDX
36
DELISTED
Accelerate Diagnostics
AXDX
$2.16M 0.88%
15,000
+2,500
+20% +$335K
SPNC
37
DELISTED
Spectranetics Corp
SPNC
$2.06M 0.84%
110,000
– –
EPZM
38
DELISTED
Epizyme, Inc
EPZM
$2.05M 0.83%
+200,000
New +$2.23M
MGNX icon
39
MacroGenics
MGNX
$252M
$2.02M 0.82%
+75,000
New +$1.69M
MDCO
40
DELISTED
Medicines Co
MDCO
$2.02M 0.82%
+60,000
New +$2.12M
XENT
41
DELISTED
Intersect ENT, Inc
XENT
$1.94M 0.79%
+150,000
New +$2.35M
OPCH icon
42
Option Care Health
OPCH
$3.64B
$1.91M 0.78%
+187,500
New +$1.91M
RDUS
43
DELISTED
Radius Health, Inc.
RDUS
$1.84M 0.75%
+50,000
New +$1.77M
RDUS
44
PUT
DELISTED
Radius Health, Inc.
RDUS
$1.84M 0.75%
+50,000
New +$1.77M
UNH icon
45
UnitedHealth
UNH
$366B
$1.76M 0.72%
+12,500
New +$1.67M
XLRN
46
DELISTED
Acceleron Pharma
XLRN
$1.7M 0.69%
50,000
-25,000
-33% -$813K
ADAP
47
DELISTED
Adaptimmune Therapeutics
ADAP
$1.63M 0.66%
200,000
-50,000
-20% -$471K
WCG
48
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.61M 0.65%
+15,000
New +$1.47M
PMC
49
DELISTED
PharMerica Corporation
PMC
$1.6M 0.65%
+65,000
New +$1.61M
MRUS
50
DELISTED
Merus
MRUS
$1.6M 0.65%
+200,000
New +$1.75M
1
2
3 4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2016 Portfolio in Review

As of Q2 2016, Iguana Healthcare Management held 116 positions worth $246M, down 9.9% from $273M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Iguana Healthcare Management withdrew a net $37.7M in Q2 2016, closing 34 positions and reducing 17 holdings. Its most notable exit was Cigna, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 68% a quarter earlier, followed by Industrials.

Against the trend, Iguana Healthcare Management opened a new position in Shire pic worth $11M.

  • Iguana Healthcare Management's largest Q2 2016 buy was Shire pic: 60,000 shares worth $11M.
  • Iguana Healthcare Management added most to Gilead Sciences in Q2 2016, an estimated $4.44M increase.
  • Iguana Healthcare Management's biggest Q2 2016 reduction was MEDIVATION, INC., cutting an estimated $14.5M.
  • Iguana Healthcare Management fully exited Cigna in Q2 2016, selling an estimated $13.2M.
  • Iguana Healthcare Management's ten largest holdings make up 37% of its $246M portfolio in Q2 2016.
  • Iguana Healthcare Management opened 41 new positions and closed 34 in Q2 2016.
  • Iguana Healthcare Management's portfolio value fell 9.9% quarter-over-quarter to $246M.

Based on Iguana Healthcare Management's 13F filing for Q2 2016, filed 15 Aug 2016.